As any reader of Ben Goldacre's blog and books will know, open data is the big debate. And the bigger the diagnostic or therapeutic implications of the data concerned, the bigger need to keep it open (or closed, depending on your proclivities). Genes and genetic studies have long been touted as the final frontier for … Continue reading DNA Digest’s Twitter Competition for Data Sharing in Genetics
I have been debating whether or not I should write this post, but eventually I decided to go ahead with it. There is no point in holding back on one's opinions, right? So, before I start off, Happy Republic Day, India; how're you feeling? This post reflects on a back-and-forth I got into with the … Continue reading My “Kunwar Amar Fiasco” and Republic Day Reflections
When TechCrunch reported that there were talks going on between Elsevier and Mendeley this January, I did not want to believe it. Being an ardent user and advocate of the platform, I wanted it to stay out of the clutches of Big Pub. But it is now official, Mendeley has been acqui-hired by Elsevier for … Continue reading Another Start-up Bites the Dust: Elsevier Buys Mendeley
Few emerging technologies have taken by storm the world as much as Facebook has. Although a plummeting share price has theoretically halved Mark Zuckerberg’s fortune (it has come down to $18.75 from its $38 IPO in May and experts say there is further room for the slide) (1) there seems to be no effect whatsoever … Continue reading Facebooking Your Faculty: To be or not to be?
This is a quickie post before I run to the gym. Hat Tip: Jon Wilkins of Lost in Transcription (and the rather wordy Darwin Eats Cake webcomics). So this is a question that has plagued me so much: what DO people do on Twitter all day? Another curious soul, Scott Golder, decided to get off … Continue reading TimeUse: What People Do On Twitter All Day